Squarepoint
BSX icon

Squarepoint’s Boston Scientific BSX Stock Holding History

Squarepoint’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6M Buy
763,700
+581,800
+320% +$31.6M 0.04% 489
2026
Q1 		$11.4M Buy
181,900
+128,100
+238% +$10.2M 0.01% 1004
2025
Q4 		$5.13M Buy
53,800
+800
+2% +$78.4K 0.01% 1435
2025
Q3 		$5.17M Sell
53,000
-429,000
-89% -$44.4M 0.01% 1446
2025
Q2 		$51.8M Buy
482,000
+302,600
+169% +$30.6M 0.05% 392
2025
Q1 		$18.1M Sell
179,400
-83,500
-32% -$8.41M 0.02% 737
2024
Q4 		$23.5M Buy
262,900
+101,900
+63% +$8.97M 0.02% 694
2024
Q3 		$13.5M Buy
161,000
+73,700
+84% +$5.81M 0.02% 791
2024
Q2 		$6.72M Sell
87,300
-120,600
-58% -$8.83M 0.01% 1172
2024
Q1 		$14.2M Buy
207,900
+67,300
+48% +$4.33M 0.02% 789
2023
Q4 		$8.13M Buy
140,600
+23,000
+20% +$1.23M 0.02% 1067
2023
Q3 		$6.21M Buy
117,600
+46,400
+65% +$2.43M 0.02% 1044
2023
Q2 		$3.85M Buy
+71,200
New +$3.72M 0.01% 1230
2023
Q1 		– Sell
-56,300
Closed -$2.61M – 3252
2022
Q4 		$2.61M Hold
56,300
– – 0.01% 1212
2022
Q3 		$2.18M Sell
56,300
-94,500
-63% -$3.79M 0.01% 1271
2022
Q2 		$5.62M Sell
150,800
-84,200
-36% -$3.43M 0.03% 612
2022
Q1 		$10.4M Buy
235,000
+26,300
+13% +$1.14M 0.04% 447
2021
Q4 		$8.87M Sell
208,700
-2,900
-1% -$122K 0.02% 568
2021
Q3 		$9.18M Sell
211,600
-92,700
-30% -$4.1M 0.03% 528
2021
Q2 		$13M Sell
304,300
-84,800
-22% -$3.57M 0.05% 372
2021
Q1 		$15M Buy
389,100
+322,500
+484% +$12.2M 0.09% 254
2020
Q4 		$2.39M Buy
66,600
+56,100
+534% +$2.02M 0.02% 848
2020
Q3 		$401K Buy
+10,500
New +$405K 0.01% 1600

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Squarepoint's BSX Position: Q2 2026 in Review

Squarepoint increased its Boston Scientific (BSX) stake by 2.2% in Q2 2026, buying an estimated $1.9M and bringing the position to 1,624,929 shares worth $69.4M. The position accounts for 0.08% of the portfolio, ranked #253.

Squarepoint first reported a position in BSX in Q2 2015 and has held it in 36 quarters since. The position peaked at $289M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Squarepoint held 1,624,929 shares of Boston Scientific worth $69.4M as of Q2 2026.
  • Squarepoint bought 35,015 Boston Scientific shares in Q2 2026, an estimated $1.9M.
  • Boston Scientific made up 0.08% of Squarepoint's portfolio in Q2 2026, its #253 holding.
  • Squarepoint first reported a position in Boston Scientific in Q2 2015 and has held it in 36 quarters since.
  • Squarepoint's Boston Scientific position peaked at $289M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.